The Pharmacy Times® Pneumococcal Resource Center is a comprehensive resource for clinical news and expert insights for any infection caused by the bacteria Streptococcus pneumoniae, or pneumococcus.
July 4th 2025
Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability to perform activities and experiencing poor quality of life.
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Diseases
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Diseases
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Diseases, Pulmonology
View More
Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Ri...
1.0 Credit / Immunization, Infectious Diseases
View More
Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the...
1.5 Credits / HIV/AIDS, Infectious Disease
View More
Beyond the Spots: Management of Measles
1.0 Credit / Infectious Disease, Immunization
View More
Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed C...
1.5 Credits / HIV/AIDS, Infectious Disease
View More
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
1.5 Credits / Immunization, Infectious Disease, Pulmonology
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases
1.0 Credit / General Pharmacy, Law
View More
Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment
1.0 Credit / Infectious Disease, Immunization
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)
1.0 Credit / General Pharmacy, Law
View More
ACIP Recommendations for Pneumococcal Vaccination
The panel of experts examines the most recent ACIP recommendations for pneumococcal vaccination in adults aged 65 and older, highlighting key updates and changes to the guidelines.
Watch
Target Patient Populations for Pneumococcal Vaccines
Krista D. Capehart, PharmD, BCACP, FAPhA, Dr. Capeheart outlines the patient populations for whom pneumococcal vaccines are indicated and provides a detailed explanation of the ACIP-recommended immunization schedules for these vaccines.
Watch
Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
The pneumococcal vaccination experts offer a comparative analysis of the five FDA-approved pneumococcal vaccines, focusing on their structural differences and the specific strains each vaccine targets.
Watch
Vaccination Efforts to Mitigate Pneumococcal Outbreaks
The panel of healthcare professionals examines how strategic vaccination can effectively mitigate pneumococcal outbreaks, thereby reducing exposure risks to vulnerable populations in healthcare settings such as nursing homes and hospitals.
Watch
Patient Burden Associated with Pneumococcal Disease
A medical professional examines the significant patient burden imposed by pneumococcal infections, highlighting how this burden drove the development of innovative vaccine technologies.
Watch
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Watch
Manifestation of Pneumococcal Disease in Adults
Medical professionals describe how pneumococcal disease manifests in adults, detailing its potentially lethal consequences such as sepsis or severe pneumonia, and explain how vaccination can effectively mitigate these serious health risks.
Watch
Symptomatology and Transmission of Pneumococcal Infection
Medical experts outline the key indicators, symptoms, and transmission mechanisms of pneumococcal infections in adult populations.
Watch
ACIP Votes to Recommend Pneumococcal 21-Valent Conjugate Vaccine for Adult Populations
July 2nd 2024The committee, after being presented evidence by the working group, recommended the vaccine for adults aged 65 and older and those 19 or older who have current recommendations to receive a pneumococcal vaccine.
Read More